Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN)

CUSIP: 83548R204

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COM NEW
Shares outstanding
6,190,476
Total 13F shares
4,300,953
Share change
-3,006,386
Total reported value
$2,106,589
Price per share
$0.49
Number of holders
23
Value change
-$696,648
Number of buys
18
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 83548R204?
CUSIP 83548R204 identifies SONN - Sonnet BioTherapeutics Holdings, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) as of Q2 2023

As of 30 Jun 2023, Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,300,953 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Virtu Financial LLC, ADVISORY SERVICES NETWORK, LLC, TWO SIGMA SECURITIES, LLC, McCollum Christoferson Group LLC, JPMORGAN CHASE & CO, and HRT FINANCIAL LP. This page lists 23 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.